Aesthetic Partners

The firm is led by Co-Founder & CEO Courtney Ellenbogen and Co-Founder & Executive Advisor Faraz Karbasi. A Head of Corporate Development, Jordan Barrett, is listed on the leadership team, suggesting a dedicated acquisitions function. The firm does not name an investment committee or disclose its capital-approval process publicly.

It operates as a private-equity-style consolidator, not a family office. It acquires and builds aesthetics practices for growth rather than managing a single family's wealth. The firm's origin and capital source are not publicly disclosed, and its structure does not match the family-office disclosure pattern.

Aesthetic Partners appears to source deals through its network of clinical leaders. Named physician partners such as Dr. Jason Pozner and Dr. John Wakelin hold system-level innovation and medical-officer roles, acting as visible clinical ambassadors. The firm also maintains a public partnership-inquiry portal on its website.

Only direct acquisitions and de novo practice openings are evident on the firm's website. There is no mention of fund-of-fund commitments, co-investment programs, or limited-partner relationships with external managers.

The firm targets established, founder-owned practices with strong local brands, offering a partnership that can include partial liquidity upfront and a path to full exit later. It also pursues de novo openings, providing start-up capital and operational support for new clinics. No early-stage venture or minority-growth equity activity is disclosed.

Aesthetic Partners concentrates exclusively on medical aesthetics, including plastic surgery and non-surgical med-spa services. No portfolio companies outside this vertical are named, and the firm has not signaled interest in adjacent areas such as dermatology-pathology labs, dental cosmetics, or general healthcare services.

Aesthetic Partners publicly names its Chief Innovation Officer, Chief Medical Officer, and Director of Scientific Education, alongside a dozen affiliated surgeon-partners. This structure signals that clinical standards sit in a separate hierarchy from the CEO, CFO, and operational leadership. Whether these roles carry formal governance rights or serve primarily as marketing and peer-recruitment functions is not detailed in public disclosures.